Microtest Laboratories and Texcel Medical have formed a strategic alliance to assist pharmaceutical manufacturers and biotechnology companies in the development of combination products. Combo products, consisting of medical devices embedded with pharmaceutical or biologics components, comprise approximately 30% of new products under development, according to a joint statement from the companies, and are growing at a 10% compound annual growth rate, with a market expected to reach $9.5 billion...